Safety & Considerations Administered by qualified dermatologists in a sterile clinical environment Regular monitoring ensures maximum safety and optimal outcomes Not recommended for pregnant women or patients with certain health conditions Real Stories, Real Results Listen to our Patients share their journey and see how personalized care and advanced treatments made all the difference
As of April 22, 2026, it was removed from FDA Category 2, but the FDA's Pharmacy Compounding Advisory Committee will not consider it for the 503A bulks list until the July 23, 2026 meeting
View Study Organ Targets Powered by Human Organ Atlas Organs and body systems affected by GHK-Cu, mapped to the Human Organ Atlas an open-access 3D portal featuring 56 organs imaged at near-cellular resolution
Users often see visible improvements within 46 weeks
Hence, it is well protected from UV rays, pollution, and other environmental factors that may lead to lightening of the skin